Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer Sylvain LadoireFrançois MartinFrançois Ghiringhelli Review 05 June 2011 Pages: 909 - 918
Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas Carmen VisusDiasuke ItoAlbert B. DeLeo Original article 16 March 2011 Pages: 919 - 929
Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105 Laurence M. WoodZhen-Kun PanYvonne Paterson Original article 23 March 2011 Pages: 931 - 942
High susceptibility of c-KIT+CD34+ precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model Rieneke van de VenSue Ellen VerbruggeTanja D. de Gruijl Original article Open access 24 March 2011 Pages: 943 - 951
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha Els M. E. VerdegaalMarten VisserSusanne Osanto Original article Open access 24 March 2011 Pages: 953 - 963
Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma Tatiana Salles de Souza MalaspinaThaís Helena GasparotoAna Paula Campanelli Original article 27 March 2011 Pages: 965 - 974
Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer Raluca A. BudiuGina Mantia-SmaldoneAnda M. Vlad Original article 02 April 2011 Pages: 975 - 984
Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma Larry D. Anderson Jr.Danielle R. CookStanley R. Riddell Original Article 03 April 2011 Pages: 985 - 997
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention? Sylvia AdamsLuba GreederAchim A. Jungbluth Original article 05 April 2011 Pages: 999 - 1007
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice Ronald P. GladueTimothy ParadisVahe Bedian Original article 12 April 2011 Pages: 1009 - 1017
A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells Chi-Chen LinYen-Ling YuChing-Liang Chu Original article 17 April 2011 Pages: 1019 - 1027
Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells Masato KatoYutaro NakamuraKingo Chida Original article 26 April 2011 Pages: 1029 - 1038
Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine Amit MahipalMizue TeraiTakami Sato Original article 26 April 2011 Pages: 1039 - 1045
B7-H4 expression associates with cancer progression and predicts patient’s survival in human esophageal squamous cell carcinoma Lu-jun ChenJing SunXue-guang Zhang Original article 26 April 2011 Pages: 1047 - 1055
Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination Chiara TieppoCorrado BetterleFabio Farinati Short communication 18 May 2011 Pages: 1057 - 1060
